#United States #Washington #ADLM #Gender Diversity #Laboratory Medicine

Introduction

The Association for Diagnostics & Laboratory Medicine (ADLM) has taken a significant step forward in addressing the needs of gender-diverse patients by releasing its first extensive guidance in the United States. This pivotal document aims to support laboratory medicine professionals as they navigate the complexities of care for patients undergoing gender-affirming hormone therapy.

The Need for Comprehensive Guidance

As society becomes more inclusive, the demand for gender-affirming care is on the rise. Laboratory professionals often encounter unique challenges when interpreting test results for patients with diverse gender identities. Hormone therapies can alter laboratory values, making it difficult to accurately assess a patient's health condition based solely on traditional reference ranges. The new guidance seeks to provide a framework for understanding these unique challenges and improving patient care.

Key Challenges Addressed

One of the primary issues highlighted in the guidance is the interpretation of lab results affected by hormone treatments. For instance, common tests related to cardiac, kidney, and liver health can yield values that may not accurately reflect a patient's medical condition due to the influence of hormone therapy. This situation necessitates a more tailored approach to evaluating test outcomes.

Additionally, many electronic health record (EHR) systems lack the necessary features to adequately capture critical information pertinent to gender-diverse patients. This can include data such as gender identity and the organs present, which are crucial for determining appropriate screenings and preventive measures. For example, transgender men may require cervical cancer screenings, but outdated EHR systems often neglect these aspects, resulting in missed opportunities for essential health checks.

Recommendations from ADLM

To tackle these challenges, the ADLM guidance emphasizes several key recommendations:

• - Individualized Reference Intervals: Laboratory professionals are encouraged to move away from a one-size-fits-all approach when determining reference intervals for lab tests. Instead, they should adopt a holistic view that considers the patient’s unique physiological profile, their hormone therapy regimen, and overall wellbeing. For example, while the recommended target concentration for estradiol in transgender women is 100–200 pg/mL, broader ranges supported by evidence should be considered to align with personalized health goals.

• - Organ Inventory Integration: The guidance proposes creating a comprehensive organ inventory to be included in the patient's EHR. This would facilitate better communication and understanding of a patient's specific health needs and allow for tailored screening and preventive care decisions.

• - Transfusion Medicine Protocols: To enhance safety and equity, standardized, evidence-based approaches for managing transfusion medicine involving transgender and nonbinary donors and recipients are advocated.

• - Respectful Autopsy Reporting: The guidance underscores the importance of accurate documentation in autopsy reports, highlighting the need for recognition of both legal sex and affirmed gender identity, and ensuring the use of preferred names and pronouns throughout the report.

The Journey Ahead

The authors of the guidance, including a diverse group of clinical chemists, pathologists, and endocrinologists, underscore that understanding lab test interpretation for gender-diverse patients is a continually evolving field. As further research and evidence emerge, it is paramount for labs, healthcare organizations, and researchers to collaborate on developing patient-centric practices that prioritize accurate interpretation, respectful documentation, and equitable healthcare.

In conclusion, the ADLM's new guidance marks a crucial progression toward improving healthcare accessibility and quality for gender-diverse individuals. By addressing these critical areas, healthcare professionals can ensure that all patients receive the respectful and competent care they deserve.